Let’s blame the drug companies for high drug prices!

  • The total impact of obesity and its related complications on the United States’ economic output has been estimated at between 4 and 8 percent of gross domestic product.
  • According to the American Diabetes Association, the annual cost of diabetes in 2017 was $327 billion, including $237 billion in direct medical expenditures and $90 billion in reduced worker productivity.
  • The effects of poor diet and inadequate physical activity at any weight — contributed to declines in life expectancy in 2015 and 2016.
  • The obesity epidemic is largely overlooked as the media continue to blame drug companies and PBM’s for high drug costs.

Continue reading

Dr. Baselga and a serious lack of judgement

  • One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.
  •  Did not follow financial disclosure rules set by the American Association for Cancer Research when he was president of the group.
  • The feedback from within the medical community has been sharp “Dr. José Baselga’s demonstrated lack of ethics by not disclosing his ties to big pharma is a cancerous lesion on the entire medical research community. SHAME, SHAME, Dr. Baselga”.

Continue reading

Most dangerous prescription drugs not opioids

  • 48.8%, nearly half of anticoagulant adverse events required a hospital stay.
  • Based on CDC data there were nearly 22,000 severe injuries, including more than 3,000 deaths, reported by patients and health care workers relating to blood thinners in 2016.
  • The annual number of people harmed by anticoagulants could be as much as ten times greater than voluntary reports indicate, reaching nearly a quarter of a million people.
  • As many as one-quarter of people with atrial fibrillation who have a low risk of stroke are given blood-thinning drugs they likely don’t need.

Continue reading

Healthcare is on the ballot in November

  • Health care continues to be one of the top issues that voters want to hear candidates talk about during their 2018 congressional campaigns.
  • One-fourth of voters say health care is the “most important issue” for 2018 candidates to discuss during their campaigns.
  • While most have seen or heard advertisements for prescription drugs, about one in seven say they have talked to their doctor as a result of seeing an advertisement for a prescription drug.

Continue reading

Frustrated with insurers, some large companies getting into their own healthcare

  • Employers have held growth in the average per-employee cost of health benefits to about 3% annually.
  • Comcast health care costs are increasing by about 1 percent a year, well below the 3 percent average of other large employers and below general inflation.
  • Their model is based on providing employees support and assistance in making the right health care decisions for themselves and their families.
  • Other employers are focusing more attention on unsatisfying hospitals and doctors.
  • Employers, including that Amazon-Berkshire-JPMorgan alliance, are increasingly unhappy with the nation’s health care systems.

Continue reading

Don’t use random data for DTC strategic decisions

  • Random marketing data via social media may not be applicable for your product/health condition.
  • Marketers need to ask “why?” and “what does this include?”
  • Perfect example is the latest health data from Rock Health.  It doesn’t differentiate between health apps and fitness apps.
  • DTC marketers need to conduct their own research and validate it with follow up research.

Continue reading